Drugs / 11C-Acetate
11C-Acetate
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT02715583 | Mar 2016 → Sep 2020 | prostate cancer | Abramson Cancer Center at Penn Medicine | Completed | No outcome recorded |
| Phase 0 | NCT00949403 | Jul 2010 → Jan 2011 | NAFLD1 | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT03924102 | Dec 2025 → Oct 2026 | heart failure | University of Alabama at Birmingham | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT00813566 | Nov 2010 → Feb 2015 | brain neoplasm, cancer | University of Utah | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02549755 | Sep 2015 → Oct 2016 | hepatocellular carcinoma | Justin Sims | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01917136 | Aug 2013 → Oct 2018 | pulmonary hypertension | University of Pennsylvania | Completed | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT01777061 | — | prostate cancer | Wendell Yap, MD | No longer available | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C] Acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03924102 ↗ |
| Known as | C-11 Acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00949403 ↗ |
| Known as | carbon-11 acetate [[11C]acetate] | “carbon-11 acetate [[11C]acetate]” NCT01777061 ↗ |
| Known as | sodium acetate [11C]Acetate injection | “sodium acetate [11C]Acetate injection” NCT01777061 ↗ |
| Modality | Diagnostic / imaging agent | “Brain scan with imaging agent” NCT00813566 ↗ |
| Route | Other | “C-11 Acetate and C-11 Palmitate will be injected” NCT00949403 ↗ |